Alzamend Neuro Ownership | Who Owns Alzamend Neuro?
Alzamend Neuro Ownership Summary
Alzamend Neuro is owned by 3.04% institutional investors, 0.53% insiders, and 96.43% retail investors. Citigroup is the largest institutional shareholder, holding 0% of ALZN shares. Fidelity Extended Market Index is the top mutual fund, with 0.42% of its assets in Alzamend Neuro shares.
ALZN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alzamend Neuro | 3.04% | 0.53% | 96.43% |
| Sector | Healthcare Stocks | 244.82% | 12.08% | -156.90% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citigroup | - | - | - |
| Morgan stanley | - | - | - |
| Clearstead advisors | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Citigroup | - | - | - |
| Morgan stanley | - | - | - |
| Clearstead advisors | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Citigroup | - | - | -5.23K |
| Clearstead advisors | - | - | -10.00K |
| Morgan stanley | - | - | -18.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | - | - | -18.00K |
| Clearstead advisors | - | - | -10.00K |
| Citigroup | - | - | -5.23K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -5.23K |
| Clearstead advisors | -10.00K |
| Morgan stanley | -18.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 12 | - | 115,483 | - | 3 | - | 12 | - | - | - |
| Sep 30, 2023 | 24 | 4.35% | 6,248,424 | 1.95% | 6 | 16.34% | 11 | 120.00% | 2 | -60.00% |
| Jun 30, 2023 | 23 | -23.33% | 6,128,982 | -1.26% | 6 | 15.64% | 5 | -16.67% | 5 | -37.50% |
| Mar 31, 2023 | 30 | -14.29% | 6,207,291 | -10.82% | 6 | 12.60% | 6 | -71.43% | 8 | 14.29% |
| Dec 31, 2022 | 35 | 105.88% | 6,960,481 | -12.10% | 7 | 10.73% | 21 | 162.50% | 7 | 75.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 19.96K | 0.42% | -13.54K |
| Vanguard Institutional Extnd Mkt Idx Tr | 7.56K | 0.16% | - |
| Fidelity Series Total Market Index | 4.64K | 0.10% | - |
| NT Ext Equity Mkt Index Fund - NL | 3.31K | 0.09% | 3.27K |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 2.40K | 0.06% | 2.37K |
| Spartan Total Market Index Pool G | 1.76K | 0.05% | - |
| Spartan Total Market Index Pool A1 | 1.76K | 0.04% | - |
| Spartan Extended Market Index Pool E | 710.00 | 0.01% | 188.00 |
| Spartan Total Market Index Pool E | 260.00 | 0.00% | - |
| Fidelity Nasdaq Composite Index | 110.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 26, 2026 | AULT MILTON C III | - | Sell | $3.12K |
| Apr 14, 2026 | AULT MILTON C III | - | Buy | $2.07K |
| Apr 14, 2026 | AULT MILTON C III | - | Buy | $108.90K |
| Dec 23, 2025 | AULT MILTON C III | - | Sell | $3.83K |
| Dec 19, 2025 | Horne William B. | - | Sell | $7.06K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 1 | - |
| 2025 Q4 | - | 10 |
| 2025 Q3 | - | 15 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | 7 | - |
ALZN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools